InsiderClue
Stocks · Health care · Services-Medical Laboratories

Fulgent Genetics, Inc.

FLGT Clue Score31
United States Fiscal year ends December CIK 0001674930 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
John C Bolger
31 May 2022
Director
Sold after exercise
500
$55.25
$27.63K
John C Bolger
31 May 2022
Director
Sold after exercise
313
$55.44
$17.35K
John C Bolger
31 May 2022
Director
Sold after exercise
313
$55.32
$17.32K
John C Bolger
1 Mar 2022
Director
Sold after exercise
625
$61.27
$38.29K
John C Bolger
1 Mar 2022
Director
Sold after exercise
625
$61.40
$38.38K
John C Bolger
1 Mar 2022
Director
Sold after exercise
625
$61.42
$38.39K
John C Bolger
30 Aug 2021
Director
Sold after exercise
312
$91.44
$28.53K
John C Bolger
30 Aug 2021
Director
Sold after exercise
312
$91.05
$28.41K
John C Bolger
30 Aug 2021
Director
Sold after exercise
312
$91.38
$28.51K
John C Bolger
1 Jun 2021
Director
Sold after exercise
1,876
$71.41
$133.97K
John C Bolger
9 Mar 2021
Director
Sold after exercise
3,374
$101.62
$342.88K
John C Bolger
17 Nov 2020
Director
Sold after exercise
4,269
$44.24
$188.88K
John C Bolger
17 Aug 2020
Director
Sold after exercise
3,914
$40.87
$159.97K
John C Bolger
22 May 2020
Director
Sold after exercise
8,677
$15.36
$133.29K
Show all 178 transactions →

What was left out

Form 4 filings counted 376
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 145
Transactions with no price 0
Shares from compensation/vesting 5,339,621
Sales filed before the plan box existed 84
History held since 4 Oct 2016